• slidebg1
    PERSONALISED TREATMENT
    Cancer & Cure
    Our idea is to customize a treatment to the cancer of each individual person.
    "Each cancer may be unique as each person"
  • slidebg1
    Research Genetic Cancer Center
    RGCC's laboratories equipped with the most advanced and state-of-the-art
    technology and equipment following "good laboratory" practices and presice procedures.
  • slidebg1
    STATE OF ART
    We use Innovative Technology to tailoring treatment more effectively to improve the lives of cancer patients.
  • slidebg1
    EARLY DETECTION
    There can be "LIFE After CANCER", the pre-requisite is "EARLY DETECTION"

Early detection of Cancer/Relapse/Reccurence can "make a real difference.."

Pre-procedure counselling is offered to determine the benefits of CTC tests..



Tests we are providing

  • Oncocount Test
    This test will report only the number of Circulating Cancer Tumor Cells (CTC’s). It does not include any other information concerning the CTC’s or Circulating Cancer Stem Cells (CSC’s) Immunophenotyping.

    Read more >
  • Oncostat Test
    This test includes the chemosensitivity / chemoresistance assessment for cytotoxic drugs, monoclonal antibodies, and small molecules that inhibit specific targets eg. (TKI, etc.). No natural substances tested.

    Read more >
  • Oncostat Extracts Test
    This test includes only the assessment of natural substances and plant extracts for any anticancer potency. No chemotherapeutic agents tested and no tumor suppressor genes tested.

    Read more >
  • Oncostat Plus Test
    This test includes the assessment of cytotoxic drugs, natural substances and plant extracts for any anticancer potency. The complete information for personal cancer care and support.

    Read more >
  • Oncotrace Test
    This test will report the number of CTC’s, any positive CSC’s, and the immunophenotype of these cells.

    Read more >
  • Oncotrail Test
    This test is a tailor made test for a specific type of malignancy such as breast cancer (Oncotrail for Breast), prostate (Oncotrail for Prostate), Colon, Melanoma, Lung, Sarcoma, Gastrointestinal for follow up control.

    Read more >
  • Metastat Test
    Markers on CTCs that point out the potential organ for relapse. It can help practitioners in the prognosis of metastases trends in cancer patients and guide them in the choice of appropriate chemotherapy.

    Read more >
  • Immunostat Test
    Profile of humoral and cellular immunity and cachexia. This test uses specific cellular markers and cytokine production to detect the type/types of cells that are responsible for activation / repression of the immune system of host.

    Read more >

"Every cancer patient is unique"
why choose our Tests?

  • Role of CTC's

    Circulating tumor cells helps in diagnosis and prognosis of cancer disease

  • Early detection of cancer

    Early detection can make a huge difference in cancer treatment

  • MRD(Minimal Residual Disease)

    Our tests helps in"Relapse/ Recurrence" of cancer disease

  • Sensitivity and Specificity

    Our results show a specificity of 83.9% and sensitivity of 86.2%

  • Chemosensitivity Test

    Road to "Personalised Treatment"

  • Integrative Treatment

    involves natural least invasive & Non Toxic therapies to treat cancer disease

What Our Doctor's Say:

Further Reading

Latest Info on CANCER

  • Journal of Biological Research-Thessaloniki

    Evaluation of a simple method for storage of blood samples that enables isolation of circulating tumor cells 96 h after sample collection.

  • Quantitative Nuclear Magnetic Resonance for the determination of Genistein in capsules

    Genistein is a natural flavonoid in which the B ring is linked to the heterocyclic ring at the C3 and can occur in foods both in free and esterified form.

  • EV-encapsulated small molecule inhibitor decreases viability in cancer cell lines

    HereinResearchGeneticCancerCentre(RGCC)weareintheprocessofdevelopinganovelsmallmoleculeERKinhibitor.

  • Molecular profiling of gastrointestinal cancer

    Background:Gastro-intestinalcancer(GI)includeavarietyofcancersthataffectesophagus,gallbladder,liver,pancreas,stomach,intestineandotherorgansinvolvedindigestivesystem.

  • Retrotransposons in circulating free DNA from cancer patients

    retrotransposons are part of non-long terminal repeat (non-LTR) retrotransposons that are positioned throughout the genome and comprise 17% of it.

  • Isolation and characterization of CTCs from breast cancer patients with and without metastasis

    Introduction:Breastcancerifoneofthemostcommontypesofmalignancyregardingfemales.Intherecentyearsanewmethodfordetectingmalignancieshasemerged

  • CD163 detection in breast cancer patients’ peripheral blood. A possible marker?

    Introduction:M2Macrophagesareasubtypeofmacrophagesthatsuppressinflammation,angiogenesis,tissueremodelingandrepair.

  • Flow cytometric analysis of CTCs in breast cancer patients before and after chemotherapy

    Breast cancer if one of the most common types of malignancy regarding females. The most prevalent methods for detecting breast cancer include mammographs, MRI, ultrasound and serum tumor markers.

  • Identification of genes involved in breast cancer and breast cancer stem cells

    Breast cancer is the most frequent type of cancer in women. Great progress has been made in its treatment but relapse is common.

  • Archives of Clinical Microbiology

    Detection and identification of bacterial contamination in blood samples from cancer patients.

  • Breast Cancer: Targets and Therapy

    Current perspectives on CHEK2 mutations in breast cancer.

  • Journal of Cancer Therapy

    Stemness Gene Profiles of Circulating Tumor Cells.

  • Risk prediction of metastasis through study of circulating tumor cells

    Risk prediction of metastasis through study of circulating tumor cells

  • PLoS One

    L1 retrotransposon expression in circulating tumor cells.

  • ANTICANCER RESEARCH International Journal of Cancer Research and Treatment

    Generation of Human Antibodies Against a Specific Peptide: a Novel Strategy Based on Human Cells.

  • Molbank Journal MDPI

    9-(4-Methoxyquinazolin-2-yl)-9H-purin-6-amine.

  • Involvement of retrotransposon L1 in stemness and cellular plasticity

    The study of Tmx2 in self-renewal and pluripotency in breast cancer

    ABSTRACT